KEUTZER TIMOTHY (Chief Development Officer) sold 1.0% of their position (3.39K shares) of SPERO THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/3/2023ACC: 0000899243-23-003948
Officer· Chief Development Officer
Since Jan 2020
+262.56K
Net shares
Net buyer
$6.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
265.96K acquired · 3.39K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+265.96K
Price / share
—
Trade value
—
% of position
411.8%
2/1/2023
64.58K→330.54K
Common Stock
Direct
Shares
−3.39K
Price / share
$1.86
Trade value
$6.31K
% of position
1.0%
2/2/2023
330.54K→327.14K
Total
Net shares
+262.56K
Net value
-$6.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2023 | A · Award | +265.96K | — | — | 411.8% | 64.58K | 330.54K |
| Common Stock Direct | 2/2/2023 | S · Sale | −3.39K | $1.86 | $6.31K | 1.0% | 330.54K | 327.14K |
| Total | +262.56K | -$6.31K | ||||||
Derivative Transactions0
No derivative transactions reported